Signaturefd, LLC Adverum Biotechnologies, Inc. Transaction History

Signaturefd, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 25, 2022	SELL	$1.74 - $2.4 $3,201 - $4,416	-1,840 Closed	0 $0
Q3 2021 Oct 28, 2021	SELL	$2.08 - $3.6 $1,245 - $2,156	-599 Reduced 24.56%	1,840 $4,000
Q2 2021 Jul 26, 2021	BUY	$3.36 - $10.56 $2,597 - $8,162	773 Added 46.4%	2,439 $9,000
Q4 2020 Feb 11, 2021	SELL	$9.84 - $14.26 $14,760 - $21,390	-1,500 Reduced 47.38%	1,666 $18,000
Q2 2020 Jul 30, 2020	BUY	$8.53 - $25.64 $25,589 - $76,920	3,000 Added 1807.23%	3,166 $66,000
Q1 2020 Apr 23, 2020	BUY	$7.98 - $16.32 $1,324 - $2,709	166 New	166 $2,000

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $612M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

Stay updated on Signaturefd, LLC with notifications on news.